SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-19-010727
Filing Date
2019-02-26
Accepted
2019-02-26 17:03:16
Documents
10

Document Format Files

Seq Description Document Type Size
1 425 a18-39904_54425.htm 425 24797
2 GRAPHIC g3990454bgi001.gif GRAPHIC 39385
3 GRAPHIC g3990454bgi002.gif GRAPHIC 129341
4 GRAPHIC g3990454bgi003.gif GRAPHIC 75205
5 GRAPHIC g3990454bgi004.gif GRAPHIC 94179
6 GRAPHIC g3990454bgi005.gif GRAPHIC 44461
7 GRAPHIC g3990454bgi006.gif GRAPHIC 93604
8 GRAPHIC g3990454bgi007.gif GRAPHIC 94286
9 GRAPHIC g3990454bgi008.gif GRAPHIC 70450
10 GRAPHIC g3990454bgi009.gif GRAPHIC 117302
  Complete submission text file 0001104659-19-010727.txt   1071265
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Subject) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-06351 | Film No.: 19634330
SIC: 2834 Pharmaceutical Preparations